Skip to main content
Premium Trial:

Request an Annual Quote

Helicos Receives $700K Cash Advance


Helicos has received a $700,000 cash advance from Atlas Venture and Flagship Ventures as part of a bridge loan agreement Helicos entered into last year with those investment firms, according to documents filed with the US Securities Exchange Commission.

The deal comes just a few weeks after Helicos reported that it would require "significant additional capital" in December to keep operating (IS 11/15/2011).

In the original financing deal, Helicos agreed to sell up to $4 million worth of convertible promissory notes to Atlas Ventures and Flagship Ventures, with a total committed purchase amount of $2 million and the right to purchase up to an additional $2 million on or before Dec. 31, 2012 (IS 11/30/2010).

As part of this latest cash advance, the firms amended the original agreement to say that Atlas and Flagship would purchase notes at least once more before Dec. 31, 2012, for no more than $1 million.

The Scan

International Team Proposes Checklist for Returning Genomic Research Results

Researchers in the European Journal of Human Genetics present a checklist to guide the return of genomic research results to study participants.

Study Presents New Insights Into How Cancer Cells Overcome Telomere Shortening

Researchers report in Nucleic Acids Research that ATRX-deficient cancer cells have increased activity of the alternative lengthening of telomeres pathway.

Researchers Link Telomere Length With Alzheimer's Disease

Within UK Biobank participants, longer leukocyte telomere length is associated with a reduced risk of dementia, according to a new study in PLOS One.

Nucleotide Base Detected on Near-Earth Asteroid

Among other intriguing compounds, researchers find the nucleotide uracil, a component of RNA sequences, in samples collected from the near-Earth asteroid Ryugu, as they report in Nature Communications.